233 related articles for article (PubMed ID: 8463894)
1. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine.
Murphy TV; Pastor P; Medley F; Osterholm MT; Granoff DM
J Pediatr; 1993 Apr; 122(4):517-23. PubMed ID: 8463894
[TBL] [Abstract][Full Text] [Related]
2. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination.
Murphy TV; White KE; Pastor P; Gabriel L; Medley F; Granoff DM; Osterholm MT
JAMA; 1993 Jan; 269(2):246-8. PubMed ID: 8417244
[TBL] [Abstract][Full Text] [Related]
3. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
[TBL] [Abstract][Full Text] [Related]
5. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines.
Mohle-Boetani JC; Ajello G; Breneman E; Deaver KA; Harvey C; Plikaytis BD; Farley MM; Stephens DS; Wenger JD
Pediatr Infect Dis J; 1993 Jul; 12(7):589-93. PubMed ID: 8346003
[TBL] [Abstract][Full Text] [Related]
6. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.
Takala AK; Eskola J; Leinonen M; Käyhty H; Nissinen A; Pekkanen E; Mäkelä PH
J Infect Dis; 1991 Nov; 164(5):982-6. PubMed ID: 1940479
[TBL] [Abstract][Full Text] [Related]
7. Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age.
Hay JW; Daum RS
Pediatr Infect Dis J; 1990 Apr; 9(4):246-52. PubMed ID: 2110651
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with sickle cell disease.
Rubin LG; Voulalas D; Carmody L
Am J Dis Child; 1992 Mar; 146(3):340-2. PubMed ID: 1543182
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group.
Wenger JD; Pierce R; Deaver KA; Plikaytis BD; Facklam RR; Broome CV
Lancet; 1991 Aug; 338(8764):395-8. PubMed ID: 1678080
[TBL] [Abstract][Full Text] [Related]
10. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Haemophilus influenzae type b vaccines in Massachusetts children 18 to 59 months of age.
Loughlin AM; Marchant CD; Lett S; Shapiro ED
Pediatr Infect Dis J; 1992 May; 11(5):374-9. PubMed ID: 1630857
[TBL] [Abstract][Full Text] [Related]
12. Finnish efficacy trials with Haemophilus influenzae type b vaccines.
Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH
J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148
[TBL] [Abstract][Full Text] [Related]
13. Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
Weinberg GA; Murphy TV; Granoff DM
Pediatrics; 1990 Oct; 86(4):617-20. PubMed ID: 2216629
[No Abstract] [Full Text] [Related]
14. Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older.
Greenberg DP; Vadheim CM; Bordenave N; Ziontz L; Christenson P; Waterman SH; Ward JI
JAMA; 1991 Feb; 265(8):987-92. PubMed ID: 1992212
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antigenuria after immunization with three Haemophilus influenzae type b conjugate vaccines.
Rothstein EP; Madore DV; Girone JA; Schiller RP; Hipp TJ; Souder RL; Bernstein HH
Pediatr Infect Dis J; 1991 Apr; 10(4):311-4. PubMed ID: 2062627
[TBL] [Abstract][Full Text] [Related]
17. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
Booy R; Heath PT; Slack MP; Begg N; Moxon ER
Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for invasive Haemophilus influenzae disease among children 2-16 years of age in the vaccine era, Switzerland 1991-1993. The Swiss H. Influenzae Study Group.
Mühlemann K; Alexander ER; Weiss NS; Pepe M; Schopfer K
Int J Epidemiol; 1996 Dec; 25(6):1280-5. PubMed ID: 9027536
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid-conjugate vaccine.
Nelson WL; Granoff DM
Am J Dis Child; 1990 Mar; 144(3):292-5. PubMed ID: 2305734
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus b disease after vaccination with Haemophilus b polysaccharide or conjugate vaccine.
Frasch CE; Hiner EE; Gross TP
Am J Dis Child; 1991 Dec; 145(12):1379-82. PubMed ID: 1669664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
